Logotipo do repositório
 

Publicação:
In silico drug design using KRASG12C as a theranostic target for pancreatic cancer

Página do item simplificado
dc.contributor.authorBarbosa, Barbara M. [UNESP]
dc.contributor.authorMartins, Allana C. F.
dc.contributor.authorGomes, Roberto S.
dc.contributor.authorRainho, Claudia A. [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionNDSU
dc.date.accessioned2023-07-29T11:38:57Z
dc.date.available2023-07-29T11:38:57Z
dc.date.issued2022-11-15
dc.description.affiliationUNESP, Botucatu, Brazil
dc.description.affiliationNDSU, Fargo, ND USA
dc.description.affiliationUnespUNESP, Botucatu, Brazil
dc.format.extent84-84
dc.identifier.citationCancer Research. Philadelphia: Amer Assoc Cancer Research, v. 82, n. 22, p. 84-84, 2022.
dc.identifier.issn0008-5472
dc.identifier.urihttp://hdl.handle.net/11449/245164
dc.identifier.wosWOS:000899825600105
dc.language.isoeng
dc.publisherAmer Assoc Cancer Research
dc.relation.ispartofCancer Research
dc.sourceWeb of Science
dc.titleIn silico drug design using KRASG12C as a theranostic target for pancreatic canceren
dc.typeResumo
dcterms.rightsHolderAmer Assoc Cancer Research
dspace.entity.typePublication

Arquivos

Coleções

Artigos